提示! 期刊投稿指南社区正式上线内测,尚有很多功能并未实现,如果您在测试过程中发现期刊信息有错误,请戳此反馈:期刊信息问题。网站功能问题,请加站长微信:620100690
  1. 首页
  2. 英文期刊BIOCHEMICAL RESEARCH METHODS

SLAS Discovery

SLAS DISCOV

ISSN:2472-5552 E-ISSN:2472-5560  出版商:SAGE Publications  国家:United States

影响因子(2024)
2.700
中科院分区(2025 官方末版)
4 区
JCR 分区
Q2
审稿周期
网友分享经验:
录用比例
暂无
收录情况  h-index:3  CiteScore:5.10
投稿入口: 投稿系统  期刊官网 

期刊简介

Advancing Life Sciences R&D: SLAS Discovery reports how scientists develop and utilize novel technologies and/or approaches to provide and characterize chemical and biological tools to understand and treat human disease. SLAS Discovery is a peer-reviewed journal that publishes scientific reports that enable and improve target validation| evaluate current drug discovery technologies| provide novel research tools| and incorporate research approaches that enhance depth of knowledge and drug discovery success. SLAS Discovery emphasizes scientific and technical advances in target identification/validation (including chemical probes| RNA silencing| gene editing technologies); biomarker discovery; assay development; virtual| medium- or high-throughput screening (biochemical and biological| biophysical| phenotypic| toxicological| ADME); lead generation/optimization; chemical biology; and informatics (data analysis| image analysis| statistics| bio- and chemo-informatics). Review articles on target biology| new paradigms in drug discovery and advances in drug discovery technologies. SLAS Discovery is of particular interest to those involved in analytical chemistry| applied microbiology| automation| biochemistry| bioengineering| biomedical optics| biotechnology| bioinformatics| cell biology| DNA science and technology| genetics| information technology| medicinal chemistry| molecular biology| natural products chemistry| organic chemistry| pharmacology| spectroscopy| and toxicology. SLAS Discovery is a member of the Committee on Publication Ethics (COPE) and was published previously (1996-2016) as the Journal of Biomolecular Screening (JBS).

投稿经验(0 条,)

数据整理自公开网络的投稿反馈,仅供参考。